At LLSC, we believe that access to treatment means getting the right treatment to the right person at the right time – wherever you live in Canada.

We amplify the voices of the blood cancer community, partnering with other cancer organizations, to influence government and decision makers so that all Canadians have timely, equitable treatment for blood cancers.

Our Access to Innovative Blood Cancer Treatment position paper tells the story of the real-life impact of the delays in public funding. Highlights of this paper include: 

• Delays impact lives: On average, we have to wait 867 days (2.5 years) for public coverage of certain blood cancer treatments. That’s not fast enough.
• Inequities harm: Coverage varies widely by province or territory — where you live determines your access to vital cancer drugs. That’s not fair enough.
• Solutions exist: New processes (e.g., Project Orbis, Target Zero) prove faster access is possible — but reforms must be adopted and equitable.
• Our call to action: Deliver the right treatment, to the right person, at the right time, no matter where they live.